Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group – PubMed
Pubmed
Related Articles
Targeted Gene Panel Testing Can Assist Patients With RCC, Germline Mutations
Read the full article here
Targeted Gene Panel Testing Can Assist Patients With RCC, Germline Mutations
Read the full article here
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial – PubMed
This trial confirms the superiority of the combination melphalan and prednisone plus thalidomide over melphalan and prednisone alone for prolonging survival in very elderly patients…
